Sign Up

Cancer, Care and Comorbidity (C3)

Research Study

posted by WM Admin on 2 June 2014


The Cancer, Care and Comorbidity (C3) project aims to address the role of comorbidity and possible unequal treatment in secondary/tertiary care services among Māori with cancer. 

The project involves two studies one quantitative and one qualitative. 


In Progress


Cancer, Comorbidity and Care: Key findings from the C3 (Quantitative) Study:

C3 (Quantitative) Study Symposium:


Health Research Council of New Zealand


Diana Sarfati
Chris Cunningham
Tony Blakely
Elizabeth Dennett
Jason Gurney
Lis Ellison-Loschmann
Jonathan B. Koea
Ken Richardson
Clare Salmond
Virginia Signal
Andrew Simpson
James Stanley
Louise Signal
Kevin Dew
Jeannine Stairmand
Maureen Holdaway
Lesley Batten

Research Abstracts

Identifying important comorbidity among cancer populations using administrative data: Prevalence and impact on survival

Ethnicity and rectal cancer management in New Zealand

Cancer-specific administrative data–based comorbidity indices provided valid alternative to Charlson and National Cancer Institute Indices

Unstaged cancer in a population-based registry: Prevalence, predictors and patient prognosis

Development of a pharmacy-based comorbidity index for patients with cancer

Incidence and management of hepatocellular carcinoma among Māori and non-Māori New Zealanders

Developing new comorbidity indices for cancer populations using administrative data

Review of methods used to measure comorbidity in cancer populations: No gold standard exists